Member Info for miavoce

I think the purpose is to move us from a position where there is limited awareness of Scancell's work and early results to a position where there is high awareness of Scancell's work and early results with major Pharma's keenly awaiting further results. Instead of Scancell needing to knock on big Pharmas' doors they will be knocking on Scancell's.

Universal could equally well mean that it can be applied to all / multiple cancers as citrullination is a common feature across them.

My point, TGTD, is that further FDA approval of parsortix is not required for labs to offer parsortix based tests in multiple cancer types (unlike what you were claiming).

Hi TGTD

you were recently stating that FDA approval is needed before labs can use Parsortix for cancer types other than MBC. Here is the definitive answer courtesy of Andrew Newland.

'I can confirm that Parsortix may be used in CLIA laboratories for multiple cancer types as long as each laboratory independently establishes and validates a Parsortix based assay specific for the purpose they require. Each laboratory has to take full responsibility for demonstrating adequate analytical performance and securing certification (through CLIA or equivalent) for their individual assays.'

Hi Bantham

I expect that CLIA labs are not confused and know exactly what they can and can't do. This is all that matters (not the confusion cased by disinformation spread by ill intentioned posters).

Wrong TGTD. CLIA labs do not need FDA approval to use parsortix for testing any cancer types. As long as the labs have validated the tests that they are offering then there is nothing stopping them from offering the test. This is why Angle are developing the Ovarian and Prostate tests (clearly there would be no point them doing this if lack of FDA approval would prevent the tests being carried out by labs).

Here you go TGTD - approx 320,000 CLIA approved labs in the US. In due course, once they are fully developed by AGL, the subset of these labs that are commercial labs could provide the Prostate and Ovarian tests using parsotix.

https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments#:~:text=In%20total%2C%20CLIA%20covers%20approximately,for%20implementing%20the%20CLIA%20Program.

TGTW, how many times must I tell you this. Parsortix can by used to clinically test any cancer when the test is developed and undertaken by a CLIA laboratory - no need for FDA approval. This is how the prostate test will be delivered for example. Also parsortix can be used to support clinical trials of any drug in any cancer type. The Angle labs are ALREADY doing this.

Read slowly and let it sink in.

Would they really travel to AACR to simply present over 2000 people with data that has been in the public domain for over 4 months ? I would hope not.

So assuming that it is Theatre layout the capacity of 20 AB is 2,214 !

Ballroom 20 is huge:-

https://d3opzdukpbxlns.cloudfront.net/9363b1db-cf64-4b46-a7b7-d0ae06a94f84/1d0965a5faa44a109a1a732773f23eaf?response-content-disposition=inline%3B%20filename%2A%3DUTF-8%27%27SDCC_Building-Map.pdf&response-content-type=application%2Fpdf&Expires=1712620800&Signature=JfT4O13hlLjFd10F-HB7YJz0kIOowv15CaT-hNajl6L62c~Vvlm2LDW5YYBDcD7ryFbfySACApPM9ZAoH57YfJsUkmXJywC~-reTj5vkD6YQOu8m~e9wLCVt8v8mXIzDKrTHJFzMZgv6aJ7RBM4Ayy6iKqDBaJrMkoxAzaqJZI3Vy83LTStSWSNUbzSH6yaDKs9ZGg2pEDQwcHGZQzZ~oreOCXJCIZlSzzxWGxNA2p8X9ECTHDVVYpuk85xjZWXXCQTflWV3bIqJjFrh0f0943A9~9aYg8QUn2J1cFJcRAQUt51S6wVBww-gl56UvuQe-kftJ6wcJVIdXSL2cqqKVw__&Key-Pair-Id=APKAI33AGAEAYCXFBDTA

Thanks for clarifying KonarA - I was under the impression that it was a late breaking abstract.

Hi KonarA - I think it is that fact that it is a late breaking abstract with embargoed content which has raised expectations of an RNS. By the very nature of the content being embargoed it must be data that hadn't been shared previously, and hence the expectation of a RNS on Monday to share the information with the market.

I agree, the volume is small beer and for multiple employees so probably relates to an internal incentive scheme for employees. I don't think we can read anything into this regarding closed periods.

TwoGoodToDie

Obviously it didn't sink in last time because you are still posting the same nonsense (deliberately no doubt).

CLIA approved labs are allowed to use Parsortix to perform laboratory developed tests on ALL cancer types. No need for FDA approval.

Results in a few weeks everybody - facts will be on the table then.

WTP - I believe it was tongue in cheek regarding the old 'cardboard labs' gag.

Good point Bob, ready made set of patients to dose.

2GTD, CLIA approved labs are allowed to use Parsortix to perform laboratory developed tests on ALL cancer types. No need for FDA approval. Let me know if that concept is too complicated for you.

350k trade after the close. This must be what held the price up despite the selling throughout the day. Maybe interest in the stock is stirring....